Abstract
Introduction: Obstructive jaundice is a common surgical problem. Percutaneous transhepatic biliary drainage (PTBD) is one of the effective treatments in the management of biliary obstruction. Hull Risk stratification index has been proposed to identify which patients are more likely to suffer from immediate and early complications and procedural mortality.Materials and Methods: This is a descriptive observational study conducted at the department of surgery TUTH over a period of 1 year between october 2014 and october 2015. Hull risk stratification index was used to predict the complications of the procedure.Results: 79 patients who underwent PTBD were included during the study period of one year. Among them 39(49%) were male and 40(51%) were female. The median age of patients undergoing the procedure was 59yrs (range 35-90yrs). Twenty nine patients (36%) were in the medium Hull risk group, 50 (64%) of patients were in the low risk group and there were no patients in the high risk group. Six patients (7.5%) died after the procedure. Seven patients (8%) developed sepsis following the procedure. One patient (1.2%) developed hemobilia. Two patients (2.4%) developed pneumonia following the procedure. The sensitivity, specificity, positive predictive value, negative predictive value of the index for complications of PTBD were 81%, 74%, 44% and 94% respectively. Patients with medium Hull’s risk were 3 times more likely to develop complications of PTBD than those with low risk.Conclusion: Hull’s Risk Stratification Index can be utilized as a marker for predicting the early, immediate complications as well as procedure related mortality.
Highlights
Conclusion: ,ƵůůƐ ZŝƐŬ ^ƚƌĂƟĮĐĂƟŽŶ /ŶĚĞdž ĐĂŶ ďĞ ƵƟůŝnjĞĚ ĂƐ Ă ŵĂƌŬĞƌ ĨŽƌ ƉƌĞĚŝĐƟŶŐ ƚŚĞ ĞĂƌůLJ ŝŵŵĞĚŝĂƚĞ ĐŽŵƉůŝĐĂƟŽŶƐĂƐǁĞůůĂƐƉƌŽĐĞĚƵƌĞƌĞůĂƚĞĚŵŽƌƚĂůŝƚLJ.
Correspondence: ƌ WƌĂďŚĂƚ :ŚĂ D^ dŚŝƌĚ LJĞĂƌ ƌĞƐŝĚĞŶƚ ĞƉĂƌƚŵĞŶƚ ŽĨ ^ƵƌŐĞƌLJ /KD dhd,͕ ŵĂŚĂƌĂũŐƵŶũ
Materials and Methods: dŚŝƐ ŝƐ Ă ĚĞƐĐƌŝƉƟǀĞ ŽďƐĞƌǀĂƟŽŶĂů ƐƚƵĚLJ ĐŽŶĚƵĐƚĞĚ Ăƚ ƚŚĞ ĚĞƉĂƌƚŵĞŶƚ ŽĨ ƐƵƌŐĞƌLJ dhd,ŽǀĞƌĂƉĞƌŝŽĚŽĨϭLJĞĂƌďĞƚǁĞĞŶŽĐƚŽďĞƌϮϬϭκĂŶĚŽĐƚŽďĞƌϮϬϭρ,ƵůůƌŝƐŬƐƚƌĂƟĮĐĂƟŽŶŝŶĚĞdžǁĂƐƵƐĞĚ ƚŽƉƌĞĚŝĐƚƚŚĞĐŽŵƉůŝĐĂƟŽŶƐŽĨƚŚĞƉƌŽĐĞĚƵƌĞ
Summary
Conclusion: ,ƵůůƐ ZŝƐŬ ^ƚƌĂƟĮĐĂƟŽŶ /ŶĚĞdž ĐĂŶ ďĞ ƵƟůŝnjĞĚ ĂƐ Ă ŵĂƌŬĞƌ ĨŽƌ ƉƌĞĚŝĐƟŶŐ ƚŚĞ ĞĂƌůLJ ŝŵŵĞĚŝĂƚĞ ĐŽŵƉůŝĐĂƟŽŶƐĂƐǁĞůůĂƐƉƌŽĐĞĚƵƌĞƌĞůĂƚĞĚŵŽƌƚĂůŝƚLJ.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.